National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody 105AD7 anti-idiotype vaccine
A cancer vaccine consisting of a humanized monoclonal antibody that mimics a tumor-associated antigen 791Tgp72 (also known as CD55). Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing CD55, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:105AD7
Abbreviation:MOAB 105AD7



Previous:modified vaccinia Ankara (Bavarian Nordic)-HER2 vaccine, Modrastane, molybdenum, mometasone furoate, monobenzone
Next:monoclonal antibody 11D10 anti-idiotype vaccine, monoclonal antibody 14G2A, monoclonal antibody 3F8, monoclonal antibody 3H1 anti-idiotype vaccine, monoclonal antibody A27.15

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov